Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
-
New hope for pancreatic cancer: drug combo before surgery shows promise
Disease control Not yet recruitingThis study tests whether adding the drug adebrelimab to standard chemotherapy before surgery can help remove pancreatic cancer more completely. About 30 adults with resectable pancreatic cancer will receive the combination treatment. The goal is to see if this approach improves t…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New combo attack shrinks untreatable liver tumors
Disease control Not yet recruitingThis study tests a powerful mix of treatments for people with liver cancer that cannot be surgically removed. It combines two types of local therapy (TACE and SBRT) with an immunotherapy drug and a targeted pill (donafenib). The goal is to see if this combination can shrink tumor…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:41 UTC